Prioritization schema for immunotherapy clinical trials in glioblastoma

Background: Emerging immunotherapeutic strategies for the treatment of glioblastoma (GBM) such as dendritic cell (DC) vaccines, heat shock proteins, peptide vaccines, and adoptive T-cell therapeutics, to name a few, have transitioned from the bench to clinical trials. With upcoming strategies and de...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Hodges, Tiffany R., Ferguson, Sherise D., Caruso, Hillary G., Kohanbash, Gary, Zhou, Shouhao, Cloughesy, Timothy F., Berger, Mitchel S., Poste, George H., Khasraw, Mustafa, Ba, Sujuan, Jiang, Tao, Mikkelson, Tom, Yung, W.K. Alfred, de Groot, John F., Fine, Howard, Cantley, Lewis C., Mellinghoff, Ingo K., Mitchell, Duane A., Okada, Hideho, Heimberger, Amy B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2016
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938323/
https://ncbi.nlm.nih.gov/pubmed/27471611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1145332
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi